Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways

Kathryn Chatfield1, Alan Eastman

  • 1Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03756, USA.

Insights

Serine/threonine protein phosphatase inhibitors block apoptosis. Protein phosphatase 2A (PP2A) inhibition protected against mitochondrial apoptosis, while Protein phosphatase 1 (PP1) inhibition protected against death receptor apoptosis.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Background:

  • Apoptosis, or programmed cell death, is a critical cellular process.
  • Serine/threonine protein phosphatases play a role in regulating apoptosis.
  • Understanding the specific roles of different phosphatases is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the specific roles of Protein phosphatase 1 (PP1) and Protein phosphatase 2A (PP2A) in apoptosis.
  • To determine which phosphatases are critical for inhibiting apoptosis induced by different pathways.

Main Methods:

  • Utilized three serine/threonine protein phosphatase inhibitors: calyculin A, okadaic acid, and tautomycin.
  • Assessed apoptosis inhibition in leukemia cell models.
  • Measured protein phosphorylation to determine effective inhibitor concentrations.
  • Investigated effects on mitochondrial pathways (Bax translocation) and death receptor pathways (Fas receptor, FADD, caspase 8).

Main Results:

  • All inhibitors prevented anisomycin-induced apoptosis, correlating with PP2A inhibition.
  • Inhibitors prevented Bax translocation to mitochondria, indicating upstream mitochondrial pathway regulation.
  • Tautomycin and calyculin A, but not okadaic acid, prevented CD95/Fas death receptor-induced apoptosis, correlating with PP1 inhibition.
  • Inhibition of Fas receptor oligomerization, FADD recruitment, and caspase 8 activation was observed.

Conclusions:

  • PP2A is critical for protecting against mitochondrial-mediated apoptosis.
  • PP1 is critical for protecting against death receptor-mediated apoptosis.
  • These findings highlight the distinct roles of PP1 and PP2A in regulating apoptosis pathways.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.